Ionis Pharma Stock Analysis, Valuation (NASDAQ:IONS)
View the Ionis Pharma stock analysis video on Amigobulls. This is our analyst opinion covering the buy and sell arguments for IONS stock.
Note: Amigobulls stock rating is our opinion based on the historical performance of the company's fundamentals. It is not indicative of the future performance of the stock.
Ionis Pharmaceuticals Inc Stock Rating 2.6/5
Amigobulls IONS stock analysis uses latest quarter 2018 Q2 financial data like Ionis Pharma revenue growth, profit margins and cash flows. We also use relative valuation metrics like PE ratio and price to sales ratio for Ionis Pharma valuation analysis. Ionis Pharma stock rating encapsulates our opinion about the company based on the fundamentals.
Should you sell IONS stock?
- Ionis Pharma reported an average operating margin of -7.45 over the Last Twelve Months (LTM).
- Ionis Pharma posted an average Net loss of -7.2% in the last twelve months.
- The company does not have profits. Hence the PE ratio is meaningless for IONS stock.
- Ionis Pharma has a negative ROE (Return On Equity) of -11.3, indicating the company is not profitable.
Ionis Pharma Related Company Stock Videos
Investors can use Amigobulls Ionis Pharma stock analysis as a tool to arrive at accurate conclusions regarding financial health of the company and its valuation. Fundamentals of a company give detailed information which helps in making invesment decisions.
Among the financials of the company, Ionis Pharma revenue growth along with the profit or net income give a clear picture of the financial health. One can also combine technical analysis and fundamental analysis to get a holistic picture about IONS stock.